Retension Pharmaceuticals, Inc.

US$11.04As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:RTSNHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap US$91.98M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$11
2.90%
(64.39%)
Hold 8|10|3|0|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.10
0.10
0.11
0.11
(0.43%)
(2.06%)
12.94%
9.99%
Revenue$M
7.882
8.349
8.457
8.751
11.23%
12.35%
14.70%
14.90%
Peers (US$91.98M)
Cap (US$)
PE
90.26M
—
90.19M
—
Capital
TTM
5Y
10Y
Leveragex
3.490
0.071
0.067
EBIT/Intx
1.630
0.199
0.176
Own earn%
5.69
(157.05)
(129.19)
Sh yield%
31.59
10.92
12.86
Owners
Insiders/Inst%
11.63
49.18
Short interest%
3.80
SBC / revenue%
2.81
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
12–17
$1 testx
—
Incr. ROIC%
8